News about "Mankind Pharma "

Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma

Actimed Therapeutics has entered into an exclusive licensing agreement with Mankind Pharma for S-pindolol, its novel therapy in development for cancer cachexia. The partnership marks a step toward delivering the first globally approved treatment for this debilitating condition to patients across India and South Asia.

Mankind Pharma | 21/11/2025 | By Dineshwori

Mankind Pharma Q2 Net Profit Falls 21 Percent to INR 520 Crore

Mankind Pharma reported a 21 percent year-on-year decline in consolidated net profit for the quarter ended September 30, 2025, with profit falling to approximately INR 520 crore from INR 661 crore in the same period last year.

Mankind Pharma | 07/11/2025 | By Darshana |  103

Mankind Pharma Partners with OpenAI to Embed AI Across Operations

Mankind Pharma has announced a strategic collaboration with OpenAI, aimed at integrating artificial intelligence across its entire value chain. The move marks one of the first times an Indian pharmaceutical company has committed to fully embedding advanced AI into its core operations.

Mankind Pharma | 18/09/2025 | By Darshana |  254

Mankind Pharma Gets CDSCO Nod to Begin Phase 1 Trials of Novel Autoimmune Drug Candidate MKP11093

Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.

Mankind Pharma | 08/09/2025 | By Darshana |  131

Mankind Pharma Expands into Sri Lanka With New Subsidiary

Mankind Pharma has incorporated a wholly owned subsidiary, Mankind Pharma Lanka (Private) Ltd., in Sri Lanka as part of its international expansion strategy.

Mankind Pharma | 26/07/2025 | By Dineshwori |  218

Mankind Pharma, Innovent Biologics to Commercialize Sintilimab for Cancer Care

This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region.

Mankind Pharma | 27/12/2024 | By Aishwarya |  302

Mankind Pharma Bags CCI Approval for BSV Acquisition

The proposed transaction involves the acquisition of 100 percent shareholding of Bharat Serums and Vaccines Ltd. (BSV) by Mankind Pharma Ltd.

Mankind Pharma | 10/10/2024 | By Aishwarya |  487

Mankind Pharma to Acquire Bharat Serums and Vaccines

Mankind Pharma has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Ltd. (BSV) from Advent International, for an enterprise value of approx. INR 13,630 Crores, subject to closing-related adjustments.

Mankind Pharma | 26/07/2024 | By Aishwarya |  642

Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India

Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.

Mankind Pharma | 22/07/2024 | By Aishwarya |  778

Mankind Pharma files DRHP with SEBI

The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1

Mankind Pharma | 19/09/2022 | By Sudeep Soparkar |  666